Clinical Trial Update: QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors [Phase 2]

View source ↗

Summary

ClinicalTrials.gov update for QUILT-3.055, a Phase 2 study of combination immunotherapies in patients who previously received immune checkpoint inhibitors. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Squamous Cell Carcinoma
• Melanoma
• Merkel Cell Carcinoma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma
• Small Cell Lung Cancer
• Urothelial Carcinoma

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Non-Small Cell Lung Cancer, Small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING